RMQHX
Price
$626.31
Change
+$18.56 (+3.05%)
Updated
Aug 22 closing price
Net Assets
976.91M
RYVYX
Price
$635.29
Change
+$18.74 (+3.04%)
Updated
Aug 22 closing price
Net Assets
1.2B
Interact to see
Advertisement

RMQHX vs RYVYX

Header iconRMQHX vs RYVYX Comparison
Open Charts RMQHX vs RYVYXBanner chart's image
Rydex Monthly Rbl NASDAQ-100® 2x Strt H
Price$626.31
Change+$18.56 (+3.05%)
VolumeN/A
Net Assets976.91M
Rydex NASDAQ-100® 2x Strategy H
Price$635.29
Change+$18.74 (+3.04%)
VolumeN/A
Net Assets1.2B
RMQHX vs RYVYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RMQHX vs. RYVYX commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMQHX is a Buy and RYVYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 1.2B vs. RMQHX (977M). RMQHX pays higher dividends than RYVYX: RMQHX (0.21) vs RYVYX (0.00). RMQHX was incepted earlier than RYVYX: RMQHX (11 years) vs RYVYX (25 years). RYVYX (1.87) and RMQHX (1.80) have similar cost to investors . RMQHX is a more actively managed with annual turnover of: 1036.00 vs. RYVYX (383.00). RMQHX (2500) and RYVYX (2500) have matching initial minimum investment requirements. RYVYX annual gain was more profitable for investors over the last year : 23.10 vs. RMQHX (9.07). RYVYX return over 5 years is better than : 112.22 vs. RMQHX (104.08).
RMQHXRYVYXRMQHX / RYVYX
Total Expense Ratio1.271.7473%
Annual Report Gross Expense Ratio1.801.8796%
Fund Existence11 years25 years-
Gain YTD18.63115.428121%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets977M1.2B81%
Annual Yield % from dividends0.210.00-
Returns for 1 year9.0723.1039%
Returns for 3 years99.97130.2677%
Returns for 5 years104.08112.2293%
Returns for 10 years1321.47911.87145%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MC72.553.17
+4.57%
Moelis & Company
NTLA10.520.40
+3.90%
Intellia Therapeutics
EDIT2.800.07
+2.56%
Editas Medicine
MBBC10.420.09
+0.91%
Marathon Bancorp Inc
NOC592.44-4.77
-0.80%
Northrop Grumman Corp